Diskussionsleitung: F. Custodis (Saarbrücken), S. B. Felix (Greifswald)
| (P1886) | Investigation of RBM20-mutation based cardiomyopathy in atrial cardiomyocytes | |
| T. A. Buchwald, S. Rebs, F. Sedaghat-Hamedani, E. Kayvanpour, B. Meder, G. Hasenfuß, K. Streckfuß-Bömeke, für die Studiengruppe: DZHK (Göttingen, Würzburg, Heidelberg) | ||
| (P1887) | Cardiac Troponin I antibodies mediate cardiomyocyte damage and alter morphology | |
| J. Furkel, V. Zirkenbach, M. Knoll, N. Frey, M. Konstandin, Z. Kaya (Heidelberg) | ||
| (P1888) | Analysis of novel cardiac biomarkers in diagnosis of decompensated heart failure | |
| T. Fröhling, M. Mirna, V. Paar, Z. Shomanova, V. van Almsick, L. J. Motloch, D. Semo, L. Makowski, A. Rukosujew, J. Sindermann, H. Reinecke, M. Lichtenauer, R. Pistulli (Münster; Salzburg, AT) | ||
| (P1889) | Comparison of the prognostic value of CT-proAVP, MR-proADM, MR-proANP, and NT-proBNP in chronic heart failure – Results from the MyoVasc Study | |
| J. Söhne, D. Velmeden, A. Schulz, S. Zeid, A. Schuch, T. Köck, S. Rapp, G. Buch, F. Müller, M. Heidorn, W. Dinh, T. Marquardt, K. Lackner, T. Gori, T. Münzel, J. Prochaska, P. S. Wild (Mainz, Wuppertal) | ||
| (P1890) | Thrombin receptors contribute to the molecular substrate for post-operative atrial fibrillation (POAF) | |
| C. Mittendorf, L. Kassler, J. Pörtner, I. Abu-Taha, M. Kamler, D. Dobrev, A. Fender (Essen) | ||
| (P1891) | Characterization of Adenosine-to-Inosine RNA editing in the human heart. | |
| K. E. Kokot, J. Kneuer, D. John, S. Rebs, M. Möbius-Winkler, M. Müller, M. Andritschke, S. Gaul, B. N. Sheikh, J. Haas, H. Thiele, O. J. Müller, S. Hille, F. Leuschner, S. Dimmeler, K. Streckfuß-Bömeke, B. Meder, U. Laufs, J.-N. Boeckel (Leipzig, Frankfurt am Main, Würzburg, Bad Oeynhausen, Heidelberg, Kiel) | ||
| (P1892) | Oxidation of mitochondrial creatine kinase in hypertrophic cardiomyopathy facilitates ROS formation and premature permeability transition pore opening through loss of its chaperone function | |
| A. Xu, F. Stadler, C. Lygate, D. Kuster, J. van der Velden, J. Dudek, A. Nickel, N. Hamdani, C. Maack, V. Sequeira (Würzburg, Bochum; Oxford, UK; Amsterdam, NL) | ||
| (P1893) | High-Throughput screen zur transkriptionellen Aktivierung eines metabolischen Zielgens zur Behandlung der Herzinsuffizienz | |
| F. Roll, M. Heckmann, D. Finke, V. Fischer, S. Hille, N. Frey, O. J. Müller, L. H. Lehmann (Heidelberg, Kiel) |